Why the study?
Statins are known to modulate proinflammatory cellular signaling and functions, but no prior studies had addressed whether they modulate pulmonary inflammation triggered by aerogenic stimuli or affect antibacterial host defense.
Does lovastatin modulate LPS-induced pulmonary inflammation and antibacterial host defense against Klebsiella pneumoniae in C57Bl/6 mice?
Does lovastatin modulate LPS-induced pulmonary inflammation and antibacterial host defense against Klebsiella pneumoniae in C57Bl/6 mice?
Answers are grounded in this paper and cite their sources.
In a murine model, lovastatin attenuates LPS-induced pulmonary inflammation via HMG-CoA reductase inhibition but concurrently impairs antibacterial host defense against Klebsiella pneumoniae.
Rationale A growing literature indicates that hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) modulate proinflammatory cellular signaling and functions. No studies to date, however, have addressed whether statins modulate pulmonary inflammation triggered by aerogenic stimuli or whether they affect host defense. Objectives To test whether lovastatin modulates LPS-induced pulmonary inflammation and antibacterial host defense. Methods To address these questions, and to confirm any effect of statins as dependent on inhibition of hydroxy-methylglutaryl coenzyme A reductase, we treated C57Bl/6 mice with three oral doses of 10 mg/kg lovastatin (or vehicle) and three intraperitoneal doses of 10 mg/kg mevalonic acid (or saline), and then exposed them to the following: (1) aerosolized LPS, (2) intratracheal keratinocyte-derived chemokine (KC), or (3) intratracheal Klebsiella pneumoniae. Measurements and main results LPS- and KC-induced airspace neutrophils were reduced by lovastatin, an effect that was blocked by mevalonic acid cotreatment. Lovastatin was also associated with reduced parenchymal myeloperoxidase and microvascular permeability, and altered airspace and serum cytokines after LPS. Native pulmonary clearance of K. pneumoniae was inhibited by lovastatin and extrapulmonary dissemination was enhanced, both reversibly with mevalonic acid. Ex vivo studies of neutrophils isolated from lovastatin-treated mice confirmed inhibitory effects on Rac activation, actin polymerization, chemotaxis, and bacterial killing. Conclusion Lovastatin attenuates pulmonary inflammation induced by aerosolized LPS and impairs host defense.
No takes yet. Share an insight, caveat, or question.
Fessler et al. (2005) studied LPS-induced pulmonary inflammation and Klebsiella pneumoniae infection. Lovastatin (with or without mevalonic acid) vs. Vehicle and/or saline was evaluated on Airspace neutrophil recruitment, pulmonary inflammation, and bacterial clearance of Klebsiella pneumoniae.
Synapse has enriched 10 related papers. Consider them for comparative context: